# Mesalamine

NDC: 0093-5907
Generic name: Mesalamine
Labeler / Manufacturer: Teva Pharmaceuticals USA, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, DELAYED RELEASE
Routes: ORAL
Marketing started: 20190509

FDA application: ANDA207873

## Active ingredients

- MESALAMINE: 400 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0093-5907"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0093-5907
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6fd0a906-e1b5-4238-a79b-a195510ddc84